Proneural-mesenchymal transition: phenotypic plasticity to acquire multitherapy resistance in glioblastoma
Glioblastoma (GBM) is an extremely aggressive tumor of the central nervous system, with a
prognosis of 12–15 months and just 3–5% of survival over 5 years. This is mainly because …
prognosis of 12–15 months and just 3–5% of survival over 5 years. This is mainly because …
Combination therapy to checkmate Glioblastoma: clinical challenges and advances
Combination therapy is increasingly becoming the cornerstone of current day antitumor
therapy. Glioblastoma multiforme is an aggressive brain tumor with a dismal median survival …
therapy. Glioblastoma multiforme is an aggressive brain tumor with a dismal median survival …
Facile synthesis of Fe3O4@ MIL-100 (Fe) towards enhancing photo-Fenton like degradation of levofloxacin via a synergistic effect between Fe3O4 and MIL-100 (Fe)
W He, Z Li, S Lv, M Niu, W Zhou, J Li, R Lu… - Chemical Engineering …, 2021 - Elsevier
Abstract The Fe 3 O 4@ MIL-100 (Fe) hybrid composites are successfully synthesized via an
in-situ growth method and characterized using various techniques. The ability of the …
in-situ growth method and characterized using various techniques. The ability of the …
The adaptive transition of glioblastoma stem cells and its implications on treatments
Glioblastoma is the most malignant tumor occurring in the human central nervous system
with overall median survival time< 14.6 months. Current treatments such as chemotherapy …
with overall median survival time< 14.6 months. Current treatments such as chemotherapy …
Developments in blood-brain barrier penetrance and drug repurposing for improved treatment of glioblastoma
Glioblastoma (GBM) is one of the most common, deadly, and difficult-to-treat adult brain
tumors. Surgical removal of the tumor, followed by radiotherapy (RT) and temozolomide …
tumors. Surgical removal of the tumor, followed by radiotherapy (RT) and temozolomide …
Glioblastoma Stem-Like Cells, Metabolic Strategy to Kill a Challenging Target
Over the years, substantial evidence has definitively confirmed the existence of cancer stem-
like cells within tumors such as Glioblastoma (GBM). The importance of Glioblastoma stem …
like cells within tumors such as Glioblastoma (GBM). The importance of Glioblastoma stem …
[HTML][HTML] Inhibition of mitochondrial translation suppresses glioblastoma stem cell growth
Glioblastoma stem cells (GSCs) resist current glioblastoma (GBM) therapies. GSCs rely
highly on oxidative phosphorylation (OXPHOS), whose function requires mitochondrial …
highly on oxidative phosphorylation (OXPHOS), whose function requires mitochondrial …
Diagnosis and management of glioblastoma: A comprehensive perspective
Glioblastoma is the most common malignant brain tumor in adults. The current management
relies on surgical resection and adjuvant radiotherapy and chemotherapy. Despite …
relies on surgical resection and adjuvant radiotherapy and chemotherapy. Despite …
Glioblastoma's next top model: novel culture systems for brain cancer radiotherapy research
Glioblastoma (GBM), the most common and aggressive primary brain tumor in adults,
remains one of the least treatable cancers. Current standard of care—combining surgical …
remains one of the least treatable cancers. Current standard of care—combining surgical …
[HTML][HTML] Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update
L Malric, S Monferran, J Gilhodes, S Boyrie, P Dahan… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Glioblastomas are malignant brain tumors with dismal prognosis despite standard treatment
with surgery and radio/chemotherapy. These tumors are defined by an important cellular …
with surgery and radio/chemotherapy. These tumors are defined by an important cellular …